Literature DB >> 18779390

Natural killer T-cell autoreactivity leads to a specialized activation state.

Xiaohua Wang1, Xiuxu Chen, Lance Rodenkirch, William Simonson, Sarah Wernimont, Rachel M Ndonye, Natacha Veerapen, Darren Gibson, Amy R Howell, Gurdyal S Besra, Gavin F Painter, Anna Huttenlocher, Jenny E Gumperz.   

Abstract

Natural killer T (NKT) cells are innate-like T cells that recognize specific microbial antigens and also display autoreactivity to self-antigens. The nature of NKT-cell autoreactive activation remains poorly understood. We show here that the mitogen-activated protein kinase (MAPK) pathway is operative during human NKT-cell autoreactive activation, but calcium signaling is severely impaired. This results in a response that is biased toward granulocyte macrophage colony-stimulating factor (GM-CSF) secretion because this cytokine requires extracellular signal-regulated kinase (ERK) signaling but is not highly calcium dependent, whereas interferon-gamma (IFN-gamma), interleukin (IL)-4, and IL-2 production are minimal. Autoreactive activation was associated with reduced migration velocity but did not induce arrest; thus, NKT cells retained the ability to survey antigen presenting cells (APCs). IL-12 and IL-18 stimulated autoreactively activated NKT cells to secrete IFN-gamma, and this was mediated by Janus kinase-signal transducers and activators of transcription (JAK-STAT)-dependent signaling without induction of calcium flux. This pathway did not require concurrent contact with CD1d(+) APCs but was strictly dependent on preceding autoreactive stimulation that induced ERK activation. In contrast, NKT-cell responses to the glycolipid antigen alpha-galactosyl ceramide (alpha-GalCer) were dampened by prior autoreactive activation. These results show that NKT-cell autoreactivity induces restricted cytokine secretion and leads to altered basal activation that potentiates innate responsiveness to costimulatory cytokines while modulating sensitivity to foreign antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779390      PMCID: PMC2581981          DOI: 10.1182/blood-2008-05-157529

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids.

Authors:  Peter Velázquez; Thomas O Cameron; Yuki Kinjo; Niranjana Nagarajan; Mitchell Kronenberg; Michael L Dustin
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

2.  Polarity of T cell shape, motility, and sensitivity to antigen.

Authors:  P A Negulescu; T B Krasieva; A Khan; H H Kerschbaum; M D Cahalan
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

3.  Differential activation of transcription factors induced by Ca2+ response amplitude and duration.

Authors:  R E Dolmetsch; R S Lewis; C C Goodnow; J I Healy
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

4.  Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells.

Authors:  Nadine Y Crowe; Adam P Uldrich; Konstantinos Kyparissoudis; Kirsten J L Hammond; Yoshihiro Hayakawa; Stephané Sidobre; Rachael Keating; Mitchell Kronenberg; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

5.  CD1 recognition by mouse NK1+ T lymphocytes.

Authors:  A Bendelac; O Lantz; M E Quimby; J W Yewdell; J R Bennink; R R Brutkiewicz
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

6.  Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium.

Authors:  E Donnadieu; G Bismuth; A Trautmann
Journal:  Curr Biol       Date:  1994-07-01       Impact factor: 10.834

7.  Involvement of p21ras activation in T cell CD69 expression.

Authors:  D D'Ambrosio; D A Cantrell; L Frati; A Santoni; R Testi
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

Review 8.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

9.  Selective activation of the calcium signaling pathway by altered peptide ligands.

Authors:  J Sloan-Lancaster; T H Steinberg; P M Allen
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.

Authors:  John Schmieg; Guangli Yang; Richard W Franck; Moriya Tsuji
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

2.  Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

Authors:  Lisa M Fox; Jennifer Miksanek; Nathan A May; Louise Scharf; Jennifer L Lockridge; Natacha Veerapen; Gurdyal S Besra; Erin J Adams; Amy W Hudson; Jenny E Gumperz
Journal:  Cancer Immun       Date:  2013-05-10

3.  CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.

Authors:  D Petrovic-Djergovic; M Popovic; S Chittiprol; H Cortado; R F Ransom; S Partida-Sánchez
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 4.  T cells specific for lipid antigens.

Authors:  Lucia Mori; Gennaro De Libero
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathway.

Authors:  Heng-Kwei Chang; Wu-Shiun Hou
Journal:  J Interferon Cytokine Res       Date:  2014-10-24       Impact factor: 2.607

6.  Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.

Authors:  Jacinto López-Sagaseta; Leah V Sibener; Jennifer E Kung; Jenny Gumperz; Erin J Adams
Journal:  EMBO J       Date:  2012-03-06       Impact factor: 11.598

Review 7.  Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.

Authors:  Madhav V Dhodapkar; Joshua Richter
Journal:  Clin Immunol       Date:  2011-01-12       Impact factor: 3.969

8.  Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.

Authors:  Jie Zhao; Xiufang Weng; Sreya Bagchi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

9.  Linking inflammation to natural killer T cell activation.

Authors:  Mariolina Salio; Vincenzo Cerundolo
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

10.  Recognition of lyso-phospholipids by human natural killer T lymphocytes.

Authors:  Lisa M Fox; Daryl G Cox; Jennifer L Lockridge; Xiaohua Wang; Xiuxu Chen; Louise Scharf; David L Trott; Rachel M Ndonye; Natacha Veerapen; Gurdyal S Besra; Amy R Howell; Mark E Cook; Erin J Adams; William H Hildebrand; Jenny E Gumperz
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.